Constellation Brands (STZ) Q1 2026 Earnings Call July 02, 2025 10:30 AM ET Speaker0 Greetings, and welcome to the Constellation Brands Q1 Fiscal Year twenty twenty six Earnings Conference Call and Webcast. At this time, all participants are in a listen only mode. A question and answer session will follow the formal presentation. As a reminder, this conference is being recorded. It's now my pleasure to introduce your host, Joseph Suarez, Vice President, Investor Relations. Please go ahead, sir. Speaker1 Than ...

Data show confirmed ORR of 83% (10/12) at doses selected for ongoing expansion study Median follow-up of 9.0 months as of the updated data cutoff Responses observed in patients with low PD-L1 and/or CLDN18.2 expression Company to host investor event on Tuesday, July 8 ROCKVILLE, Md., July 02, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (the Company), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer, today announced the present ...

Virtu shareholders who have continuously held Virtu shares since prior to November 7, 2018, can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to them whatsoever. Learn more or join by clicking https://grabarlaw.com/the-latest/Virtu-shareholder- investigation/, contact Joshua H. Grabar at jgrabar@grabarlaw.com, or call 267-507-6085. WHY: Key allegations of an underlying federal securities fraud class action complaint have survived Defendants' ...

LOS ANGELES, July 2, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Fortrea Holdings, Inc. ("Fortrea" or "the Company") (NASDAQ: FTRE) for violations of the federal securities laws. Shareholders who purchased the Company's securities between July 3, 2023 and February 28, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before August 1, 2025. DJS Law Group DJS Law Group CASE DETAILS: The complaint alleges that the Company made false and misl ...

ExxonMobil mentioned on its recent earnings call that it aims to slash its breakeven costs to $35 per barrel by 2027 and $30 per barrel by 2030. Thus, XOM's upstream operations, which derive the majority of earnings, will probably remain profitable even if there is a plunge in oil prices in the future. It can also be said that the integrated major stands to earn substantially more from its upstream business, reflecting its strong footprint in the most prolific Permian basin, when prices climb. Exxon Mobil C ...

Key Takeaways Shares of RYAAY have gained 32.3% so far this year against the 5.5% decline of the Zacks Airline industry. Ryanair Holdings (RYAAY) , a European carrier, reported solid traffic numbers for June 2025, driven by upbeat air-travel demand. The number of passengers transported on Ryanair flights was 19.9 million in June 2025, reflecting a 3% year-over-year increase. Apart from a year-over-year surge, RYAAY's June traffic also reflects a straight six-month improvement at a stretch from the beginning ...

Key Takeaways Genpact (G) has had an impressive run over the past year. Its shares have rallied 41.3%, outperforming the 7.4% rise of the Computers - IT Services industry and the 11.7% growth of the Zacks S&P 500 composite. Image Source: Zacks Investment Research G has an impressive Growth Score of B. This style score condenses all the essential metrics from the company's financial statements to get the true sense of its quality and sustainability of growth. The Zacks Consensus Estimate for this Zack Rank # ...

The Zacks Medical - Outpatient and Home Healthcare industry has been witnessing a rapid shift toward digital healthcare treatment. In the past few years, there has been a significant rise in demand for telemedicine-focused online medical and artificial intelligence (AI)-powered technology services. The rising elderly global population is necessitating many healthcare companies that were traditionally not technology-based to provide technology- enabled services to survive in the market. Per a report by Grand ...

Making a Living Drug Readily Accessible to Patients in Need Transforming the Treatment of Cancer and Autoimmune Diseases with Off-the-shelf, Multiplexed-engineered, iPSC-derived Cellular Immunotherapy February 2025 - 1 - Forward-Looking Statements This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the safety and therapeutic potential of the Company's product candidates, the advancement of and plan ...

公司概况 - 公司业务起步时自行调研获取数据进行分析，大数据时代调研成为数据补丁，能为客户提供完整数据支持，较纯依赖大数据企业更具优势 [2] - 软件业务发展战略是业务经验模型化、模型算法化、算法软件化，核心竞争力是具备咨询公司基因，能识别需求、沉淀行业知识并建立模型，运用人工智能技术开发数据智能软件 [2] - 业务从数据收集与人工分析向自动分析转型，追求模型创新构建能力，使建模成常规手段 [3] 业务与技术落地 - 秉承问题导向，开发数据智能管理与分析模块，结合行业知识、算法模型与大模型技术形成数字化解决方案，应用效果获客户认可 [3] - 在“12345 政务服务便民热线”领域开发响应性算法模型机制，技术泛化能力可用于其他行业；结合相关算法开发派单系统；开发多种自助分析工具；开发事理图谱，搭建知识图谱生产五层框架，提高城市治理应用系统开发效率 [4] 知识图谱与大模型关系 - 整合零点有数与海乂知技术，知识图谱提供可解释逻辑骨架，解决大模型“幻觉”问题，提升大模型准确度；大模型打破知识图谱更新难题，解决构建高成本问题 [5] - 认为“图谱骨架 + 大模型引擎”深度融合将在多场景抢占数智先机，知识图谱与大模型技术混合智能决策已在部分客户落地，在非生成领域提升推理逻辑可解释性 [5] 知识图谱应用与融合 - 海乂知特种领域本体构建经验可复制到民用场景，如政务“政策推荐”借鉴特种业务情报分析框架提高精准度，其知识图谱技术积累有助于公司向多领域扩展 [5]